Inhaled budesonide - Fu Mote Luo powder efficacy of treatment of bronchial asthma.docVIP

Inhaled budesonide - Fu Mote Luo powder efficacy of treatment of bronchial asthma.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Inhaled budesonide - Fu Mote Luo powder efficacy of treatment of bronchial asthma

 PAGE \* MERGEFORMAT 9 Inhaled budesonide / Fu Mote Luo powder efficacy of treatment of bronchial asthma [Abstract] Objective: To observe the inhalation of budesonide / Fu Mote Luo powder (the letter will be Turbuhaler treatment of adults with moderate persistent asthma. Methods: The inhalation of the letter will be all over, each suction 160mg/0.45g, 2 suction / times, 2 times a day for 12 weeks, patients were observed before treatment, and drug absorption after 2 weeks, 4 weeks, 12 weeks of peak expiratory flow (PEF and forced expiratory volume in one second (FEV1 changes before and after treatment The total efficiency. Results: After treatment, symptoms were improved, the total effective rate 88.56%. PEF and FEV1 were significantly improved after treatment was significantly (P lt;0.01. Conclusion: The letter must reduce the airway may have security inflammation, improve lung function and clinical symptoms, easy to use, is the ideal drug for the treatment of asthma. [Keywords:] budesonide / Fu Mote Luo Gan powder, bronchial asthma Respiratory Bronchial asthma is a common and frequently-occurring disease, clinical research received wide attention in recent years. United hormone and long-acting inhaled 2 agonist treatment of moderate to severe persistent asthma, the role and status have been able to fully affirmed .2006 Asthma prevention and control initiatives worldwide (GINA Expert Committee recommended a new strategy for asthma management, which will contain budesonide and formoterol inhalation preparation of compound (the letter must be both stable and Paul used to relieve symptoms of asthma, ie SMART therapy (letter of guarantee will be both maintained and remission therapy [1]. This study is based on 35 cases of outpatient GINA requires moderate persistent asthma have insurance with the letter will be treated, observed before and after treatment in patients with symptoms and pulmonary function changes letter will be to further explore both the ef

您可能关注的文档

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档